Last Updated: 05 Jun 2025
Source: Statifacts
The U.S. digital pathology market size accounted for USD 369.77 million in 2024 and is predicted to touch around USD 1,365.76 million by 2034, growing at a CAGR of 13.95% from 2025 to 2034.
| Industry Worth | Details |
| Market Size in 2025 | USD 421.72 Million |
| Market Size by 2034 | USD 1,365.76 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 13.95% |
The U.S. digital pathology market is exhibiting robust growth due to growing healthcare systems catering to a high demand for healthcare needs and better technology. Overall, many of the hospitals and laboratories in the U.S. are implementing digital imaging of tissue samples in place of glass slides to expedite results. With digital pathology, physicians are able to share images faster from anywhere in the country. Many pharmaceutical companies in the United States are using artificial intelligence (AI) in a growing number of clinics and institutions to help pathologists find diseases sooner and with greater accuracy, like cancer. There are many levels of the government furthering support for digital tools in healthcare, which will foster growth in the digital pathology market as well.
Some of the key players, like Philips in the U.S., along with Roche’s outreach in the U.S., are putting more focus on developing digital pathology solutions, which will lead to more competition. With the increasing number of people in the U.S. living with chronic diseases, there is a growing need for physicians to find a more timely and efficient way to review tissue specimens. The U.S. has excellent internet connectivity and access to cloud-based storage of medical data, that have helped advance the digital pathology market.
The market trends in the United States digital pathology market are defined by government support through organizations such as the Food and Drug Administration, along with the rising use of artificial intelligence-based algorithms, speeding up the digital processes.
There are many opportunities in the U.S. digital pathology market due to high demand and a robust healthcare infrastructure that allows for smoother implementation of new technology.
Published by Kesiya Chacko
